<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR54">
 <label>54.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gowen</surname>
    <given-names>BB</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>M-H</given-names>
   </name>
   <name>
    <surname>Jung</surname>
    <given-names>K-H</given-names>
   </name>
   <name>
    <surname>Smee</surname>
    <given-names>DF</given-names>
   </name>
   <name>
    <surname>Morrey</surname>
    <given-names>JD</given-names>
   </name>
   <name>
    <surname>Furuta</surname>
    <given-names>Y</given-names>
   </name>
  </person-group>
  <article-title>Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models</article-title>
  <source>Antivir Res</source>
  <year>2010</year>
  <volume>86</volume>
  <fpage>121</fpage>
  <lpage>127</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2009.10.015</pub-id>
  <?supplied-pmid 19874853?>
  <pub-id pub-id-type="pmid">19874853</pub-id>
 </element-citation>
</ref>
